Notice: This company has been marked as potentially delisted and may not be actively trading. Amedica (AMDA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends AMDA vs. INFU, SGHT, PDEX, TELA, MGRM, LUCD, NSPR, SRTS, GUTS, and ICCMShould you be buying Amedica stock or one of its competitors? The main competitors of Amedica include InfuSystem (INFU), Sight Sciences (SGHT), Pro-Dex (PDEX), TELA Bio (TELA), Monogram Orthopaedics (MGRM), Lucid Diagnostics (LUCD), InspireMD (NSPR), Sensus Healthcare (SRTS), Fractyl Health (GUTS), and IceCure Medical (ICCM). These companies are all part of the "medical" sector. Amedica vs. InfuSystem Sight Sciences Pro-Dex TELA Bio Monogram Orthopaedics Lucid Diagnostics InspireMD Sensus Healthcare Fractyl Health IceCure Medical Amedica (NASDAQ:AMDA) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, community ranking, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Which has more risk and volatility, AMDA or INFU? Amedica has a beta of -1.24, indicating that its share price is 224% less volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. Is AMDA or INFU more profitable? InfuSystem has a net margin of 1.12% compared to Amedica's net margin of -139.62%. InfuSystem's return on equity of 2.78% beat Amedica's return on equity.Company Net Margins Return on Equity Return on Assets Amedica-139.62% -148.60% -67.83% InfuSystem 1.12%2.78%1.41% Which has stronger earnings & valuation, AMDA or INFU? InfuSystem has higher revenue and earnings than Amedica. Amedica is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmedica$11.23M3.42-$9.32M-$3.13-1.04InfuSystem$134.86M0.87$870K$0.1055.45 Do analysts rate AMDA or INFU? InfuSystem has a consensus target price of $13.00, suggesting a potential upside of 134.45%. Given InfuSystem's stronger consensus rating and higher possible upside, analysts clearly believe InfuSystem is more favorable than Amedica.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amedica 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 4.00 Does the media favor AMDA or INFU? In the previous week, InfuSystem had 11 more articles in the media than Amedica. MarketBeat recorded 11 mentions for InfuSystem and 0 mentions for Amedica. Amedica's average media sentiment score of 0.00 beat InfuSystem's score of -0.51 indicating that Amedica is being referred to more favorably in the media. Company Overall Sentiment Amedica Neutral InfuSystem Negative Do insiders and institutionals hold more shares of AMDA or INFU? 3.7% of Amedica shares are held by institutional investors. Comparatively, 71.1% of InfuSystem shares are held by institutional investors. 0.9% of Amedica shares are held by insiders. Comparatively, 10.2% of InfuSystem shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in AMDA or INFU? Amedica received 300 more outperform votes than InfuSystem when rated by MarketBeat users. However, 100.00% of users gave InfuSystem an outperform vote while only 64.90% of users gave Amedica an outperform vote. CompanyUnderperformOutperformAmedicaOutperform Votes30764.90% Underperform Votes16635.10% InfuSystemOutperform Votes7100.00% Underperform VotesNo Votes SummaryInfuSystem beats Amedica on 15 of the 18 factors compared between the two stocks. Remove Ads Get Amedica News Delivered to You Automatically Sign up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMDA vs. The Competition Export to ExcelMetricAmedicaSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.46M$4.27B$5.64B$7.98BDividend YieldN/A39.85%4.89%4.05%P/E Ratio-1.0428.0923.6318.86Price / Sales3.4249.83375.50119.35Price / CashN/A51.0838.0534.64Price / Book1.805.996.914.22Net Income-$9.32M$67.09M$3.18B$246.92M Amedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMDAAmedicaN/A$3.24-0.9%N/A+2,454.7%$38.46M$11.23M-1.04N/AINFUInfuSystem1.4315 of 5 stars$6.45-0.3%$13.00+101.6%N/A$137.13M$132.78M107.50410SGHTSight Sciences3.0287 of 5 stars$2.45-0.8%$4.42+80.3%-38.4%$124.35M$79.54M-2.40210PDEXPro-Dex3.3895 of 5 stars$34.78+1.3%$52.00+49.5%+168.5%$113.42M$61.00M17.30140Analyst DowngradeInsider TradeShort Interest ↓News CoverageTELATELA Bio3.5786 of 5 stars$2.39+2.1%$9.25+287.0%-57.7%$94.14M$68.65M-1.41120Upcoming EarningsShort Interest ↓News CoveragePositive NewsMGRMMonogram Orthopaedics3.0342 of 5 stars$2.37+2.6%$4.00+68.8%-1.3%$81.32M$364,999.00-5.0428Earnings ReportNews CoverageLUCDLucid Diagnostics2.2078 of 5 stars$1.35+3.5%$3.63+169.5%+4.8%$79.22M$4.19M-1.1770Short Interest ↑NSPRInspireMD2.265 of 5 stars$2.98flat$4.75+59.4%+14.2%$77.73M$6.82M-3.9750Analyst ForecastNews CoverageSRTSSensus Healthcare2.8475 of 5 stars$4.59+3.0%$14.67+219.9%+29.0%$75.13M$41.81M11.4640Analyst ForecastShort Interest ↓News CoverageGUTSFractyl Health1.7314 of 5 stars$1.52+1.0%$10.00+560.1%-80.9%$72.87M$97,000.00-0.12102Positive NewsICCMIceCure Medical2.7995 of 5 stars$1.31+0.8%$2.70+106.1%+7.3%$72.71M$3.67M-4.5260Short Interest ↓ Remove Ads Related Companies and Tools Related Companies InfuSystem Competitors Sight Sciences Competitors Pro-Dex Competitors TELA Bio Competitors Monogram Orthopaedics Competitors Lucid Diagnostics Competitors InspireMD Competitors Sensus Healthcare Competitors Fractyl Health Competitors IceCure Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMDA) was last updated on 3/13/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
